The 60-second version of Quick Heal Technologies Limited — what it does, how it earns, and who it competes with, before any of the numbers below.
No clear supporting case emerges from the available numbers.
| Metric | FY23 | FY24 | FY25 | FY26 | 3Y CAGR |
|---|---|---|---|---|---|
| Revenue | ₹278 Cr | ₹292 Cr | ₹280 Cr | ₹261 Cr | -2.1% |
| EBITDA | ₹10 Cr | ₹25 Cr | ₹1 Cr | -₹18 Cr | — |
| EBITDA Margin | 3.6% | 8.6% | 0.2% | -6.9% | — |
| PAT (Net Profit) | ₹6 Cr | ₹24 Cr | ₹5 Cr | -₹11 Cr | — |
| EPS | ₹1.14 | ₹4.48 | ₹0.91 | ₹-1.98 | — |
| ROE | 1.5% | 5.5% | 1.1% | -2.5% | — |
| ROCE | 1.9% | 6.0% | 0.3% | -4.7% | — |
| Total Debt | — | — | ₹0 Cr | ₹0 Cr | — |
| Free Cash Flow | ₹27 Cr | ₹11 Cr | -₹37 Cr | -₹0 Cr | — |
| Company | P/E | ROE |
|---|---|---|
| TATA CONSULTANCY SERV LT | 17.3x | 45.6% |
| INFOSYS LIMITED | 15.8x | 32.0% |
| HCL TECHNOLOGIES LTD | 20.4x | 24.6% |
| WIPRO LTD | 14.5x | 15.9% |
Poor scores on business quality without a price low enough to compensate. There is no obvious argument for owning this over a stronger company at a similar valuation. 3 high-severity red flags sit above this conclusion and should be read first.